| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ... New England Journal of Medicine 369 (18), 1691-1703, 2013 | 6642 | 2013 |
| Abiraterone and increased survival in metastatic prostate cancer JS De Bono, CJ Logothetis, A Molina, K Fizazi, S North, L Chu, KN Chi, ... New England Journal of Medicine 364 (21), 1995-2005, 2011 | 5012 | 2011 |
| First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ... New England Journal of Medicine 371 (23), 2167-2177, 2014 | 3557 | 2014 |
| Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy MS Czuczman, AJ Grillo-Lopez, CA White, M Saleh, L Gordon, ... Journal of Clinical Oncology 17 (1), 268-268, 1999 | 1207 | 1999 |
| Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura JB Bussel, G Cheng, MN Saleh, B Psaila, L Kovaleva, B Meddeb, ... New England Journal of Medicine 357 (22), 2237-2247, 2007 | 994 | 2007 |
| Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin’s lymphoma TE Witzig, IW Flinn, LI Gordon, C Emmanouilides, MS Czuczman, ... Journal of clinical oncology 20 (15), 3262-3269, 2002 | 889 | 2002 |
| Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin’s lymphomas MS Kaminski, AD Zelenetz, OW Press, M Saleh, J Leonard, ... Journal of clinical oncology 19 (19), 3918-3928, 2001 | 712 | 2001 |
| Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study G Cheng, MN Saleh, C Marcher, S Vasey, B Mayer, M Aivado, M Arning, ... The Lancet 377 (9763), 393-402, 2011 | 692 | 2011 |
| Phase I study of anti–epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer F Robert, MP Ezekiel, SA Spencer, RF Meredith, JA Bonner, MB Khazaeli, ... Journal of clinical oncology 19 (13), 3234-3243, 2001 | 662 | 2001 |
| Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin’s lymphomas JM Vose, RL Wahl, M Saleh, AZ Rohatiner, SJ Knox, JA Radford, ... Journal of clinical oncology 18 (6), 1316-1323, 2000 | 441 | 2000 |
| Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study MN Saleh, JB Bussel, G Cheng, O Meyer, CK Bailey, M Arning, A Brainsky Blood, The Journal of the American Society of Hematology 121 (3), 537-545, 2013 | 417 | 2013 |
| Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial GA Wiseman, LI Gordon, PS Multani, TE Witzig, S Spies, NL Bartlett, ... Blood, The Journal of the American Society of Hematology 99 (12), 4336-4342, 2002 | 385 | 2002 |
| Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT … TM Beer, CW Ryan, PM Venner, DP Petrylak, GS Chatta, JD Ruether, ... Journal of Clinical Oncology 25 (6), 669-674, 2007 | 380 | 2007 |
| Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer J O'Shaughnessy, L Schwartzberg, MA Danso, KD Miller, HS Rugo, ... Journal of clinical oncology 32 (34), 3840-3847, 2014 | 360 | 2014 |
| Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression D Tripathy, DJ Slamon, M Cobleigh, A Arnold, M Saleh, JE Mortimer, ... Journal of Clinical Oncology 22 (6), 1063-1070, 2004 | 356 | 2004 |
| Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer AW Tolcher, S Sugarman, KA Gelmon, R Cohen, M Saleh, C Isaacs, ... Journal of Clinical Oncology 17 (2), 478-478, 1999 | 344 | 1999 |
| Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study RSM Wong, MN Saleh, A Khelif, A Salama, MSO Portella, P Burgess, ... Blood, The Journal of the American Society of Hematology 130 (23), 2527-2536, 2017 | 299 | 2017 |
| Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers JA Bonner, KP Raisch, HQ Trummell, F Robert, RF Meredith, SA Spencer, ... Journal of Clinical Oncology 18 (21; SUPP), 47s-53s, 2000 | 299 | 2000 |
| A Pilot Trial of Vitaxin, A Humanized Anti-Vitronectin Receptor (anti αvβ3) Antibody in Patients with Metastatic Cancer JA Posey, MB Khazaeli, A DelGrosso, MN Saleh, CY Lin, W Huse, ... Cancer Biotherapy and Radiopharmaceuticals 16 (2), 125-132, 2001 | 293 | 2001 |
| Phase I Trial of a Ligand Fusion-Protein (DAB389IL-2) in Lymphomas Expressing the Receptor for Interkeukin-2 CF LeMaistre, MN Saleh, TM Kuzel, F Foss, LC Platanias, G Schwartz, ... Blood, The Journal of the American Society of Hematology 91 (2), 399-405, 1998 | 265 | 1998 |
